Procter & Gamble (PG) Aktievy
Procter & Gamble Company tillhandahåller konsumentförpackade varor under varumärken över hela världen. Mer information
| Snöflinga Score | |
|---|---|
| Värdering | 4/6 |
| Framtida tillväxt | 2/6 |
| Tidigare resultat | 3/6 |
| Finansiell hälsa | 3/6 |
| Utdelningar | 5/6 |
PG Community Fair Values
Create NarrativeSee what 629 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Top Community Narratives
The Procter & Gamble Company Konkurrenter
Prishistorik och prestanda
| Historiska aktiekurser | |
|---|---|
| Aktuell aktiekurs | US$144.26 |
| 52 veckors högsta | US$167.25 |
| 52 veckors lägsta | US$137.62 |
| Beta | 0.38 |
| 1 månads förändring | -1.25% |
| 3 månaders förändring | 1.90% |
| 1 års förändring | -6.17% |
| 3 års förändring | -5.16% |
| 5 års förändring | -0.50% |
| Förändring sedan börsintroduktionen | 9,827.58% |
Senaste nyheter och uppdateringar
Uppdatering av berättelse • Aug 08
10-K Update
Updated with the most recent annual report.Seeking Alpha • Aug 03
Procter & Gamble: Buy This Dividend Aristocrat Before Growth Reaccelerates
Summary Procter & Gamble is trading near its 52-week low, offering a 3% dividend yield and a forward P/E of 20.6x, below its 10-year average. PG demonstrates resilient earnings, a strong brand portfolio, and innovation-led growth, especially in China and Latin America, despite recent consumer demand headwinds. AI-driven innovation and supply chain upgrades position the company for EPS growth and improved productivity, with catalysts not fully priced in. PG's AA- balance sheet, Dividend Aristocrat status, and low beta provide defensive, attractive risk-adjusted returns. Read the full article on Seeking AlphaRecent updates
Uppdatering av berättelse • Aug 08
10-K Update
Updated with the most recent annual report.Seeking Alpha • Aug 03
Procter & Gamble: Buy This Dividend Aristocrat Before Growth Reaccelerates
Summary Procter & Gamble is trading near its 52-week low, offering a 3% dividend yield and a forward P/E of 20.6x, below its 10-year average. PG demonstrates resilient earnings, a strong brand portfolio, and innovation-led growth, especially in China and Latin America, despite recent consumer demand headwinds. AI-driven innovation and supply chain upgrades position the company for EPS growth and improved productivity, with catalysts not fully priced in. PG's AA- balance sheet, Dividend Aristocrat status, and low beta provide defensive, attractive risk-adjusted returns. Read the full article on Seeking AlphaAnalysartikel • Aug 02
Analysts Have Made A Financial Statement On The Procter & Gamble Company's (NYSE:PG) Full-Year Report
Last week saw the newest yearly earnings release from The Procter & Gamble Company ( NYSE:PG ), an important milestone...Analysartikel • Jun 21
Procter & Gamble (PG) Stock Could Be 19.5% Undervalued After Broad Based Growth
Procter & Gamble (PG) is back in the spotlight after reporting broad-based growth across core brands like Tide, Pampers, and Gillette, along with fresh marketing moves and continued dividend and buyback activity. See our latest analysis for Procter & Gamble. Despite the fresh product launches and media partnerships, Procter & Gamble’s recent share price return has been steady rather than dramatic, with a 30-day share price return of 4.11% and a 90-day share price return of 4.44%, while the...
Uppdatering av berättelse • Jun 16
PG: Cost Productivity And AI Investments Will Support Future Shareholder Returns
Analysts have slightly reduced their price target on Procter & Gamble to about $163.43 from about $163.77, reflecting small adjustments to revenue growth expectations, profit margin assumptions and the projected future P/E multiple. What's in the News P&G raised its quarterly dividend by 3% to US$1.0885 per share, marking the 70th consecutive annual increase, and plans to return about US$15b to shareholders in fiscal 2026 through roughly US$10b in dividends and US$5b in share repurchases.Uppdatering av berättelse • Jun 01
PG: Cost Productivity And Portfolio Strength Will Support Future Shareholder Returns
Analysts have slightly reduced their price target on Procter & Gamble to $163.77 from $164.09, reflecting updated assumptions around discount rates, revenue growth, profit margins, and future P/E multiples. What's in the News P&G reported fiscal Q3 2026 net sales of US$21.24b with 3% organic sales growth and core EPS of US$1.59, ahead of analyst expectations, while maintaining full year 2026 guidance for core EPS of US$6.83 to US$7.09 and organic sales growth of 1% to 5% (source: Q3 2026 earnings reports).Uppdatering av berättelse • May 04
PG: Brand Partnerships And Product Pipeline Will Support Future Shareholder Returns
Analysts have trimmed their Procter & Gamble price target slightly to about $164.09, reflecting modestly lower assumptions for revenue and profit margins while applying a slightly higher future P/E outlook. What's in the News P&G maintained fiscal 2026 guidance, with all-in sales growth expected in a 1% to 5% range and diluted EPS growth targeted in a 1% to 6% range versus fiscal 2025 diluted EPS of US$6.51 (Corporate guidance).Uppdatering av berättelse • Apr 20
PG: Buybacks And Brand Partnerships Will Support Future Shareholder Returns
Analysts have slightly reduced their price target on Procter & Gamble to $164.18 from $166.95, reflecting modestly lower assumptions for revenue growth, profit margins, fair value, and future P/E multiples. What's in the News P&G revised its fiscal 2026 diluted EPS growth outlook to a range of 1% to 6%, from a prior range of 3% to 9%, citing higher non core restructuring charges, while keeping all in sales growth guidance at 1% to 5% versus the prior year (Corporate guidance).Uppdatering av berättelse • Apr 05
PG: Share Repurchases And Premium Portfolio Refresh Will Support Future Returns
Analysts have slightly reduced their average price target for Procter & Gamble to about $167 from $168, reflecting updated views on margins and forward P/E assumptions while keeping core growth expectations largely intact. What's in the News OLAY shared new skin aging research at the 2026 American Academy of Dermatology meeting, focusing on cell adhesion as a key factor in visible aging and applying these findings to peptide based products across the Regenerist line and the new Regenerist Treatments collection (Product announcement).Uppdatering av berättelse • Mar 22
PG: Product Refresh And Buybacks Will Support Future Earnings Resilience
Analysts kept their Procter & Gamble price target steady at $168. This reflects largely unchanged views on fair value, discount rate, revenue growth, profit margin, and future P/E assumptions.Uppdatering av berättelse • Mar 08
PG: Brand Refresh And Buybacks Will Support Stable Earnings Outlook
Analysts have maintained their Procter & Gamble price target at $168, reflecting unchanged assumptions around revenue growth, profit margins, and future P/E. This suggests that recent research has not materially shifted their valuation view.Uppdatering av berättelse • Feb 21
PG: Brand Activity And Buybacks Will Support Stable Margins And Outlook
Analysts have nudged their price target for Procter & Gamble higher to $168.00 from $167.45, reflecting updated assumptions for revenue growth, slightly higher profit margins and a marginally lower future P/E multiple. What's in the News Tide launched Tide evo, a 100% concentrated, waterless laundry tile with six cleaning layers and no plastic bottles, positioned to address demand for products that align with hygiene and sustainability preferences in the U.S. (Product related announcement) Head & Shoulders introduced BARE Itchy Scalp Relief Serum, aimed at providing clinically tested dandruff protection and itch relief between washes, with a nationwide U.S. launch planned for January 2026.Uppdatering av berättelse • Feb 07
PG: Premium Brand Extensions And Stable Margins Will Support A Balanced Outlook
Analysts have nudged their price target on Procter & Gamble slightly higher to US$167.45 from about US$165.32, reflecting updated assumptions for fair value, discount rate, revenue growth, profit margins and future P/E. What's in the News Old Spice launched the Spice Alchemist collection, a premium cologne-infused deodorant, body wash and body mist line positioned against high end fragrances.Uppdatering av berättelse • Jan 25
Q2 2026 Update
Update narrative with most recent financial statements.Uppdatering av berättelse • Jan 23
PG: Share Repurchases And Margin Pressures Will Shape A Balanced Outlook
Analysts have trimmed their price target on Procter & Gamble to US$165 from US$168, citing updated views on revenue growth, profit margins, and the future P/E multiple. What's in the News P&G updated its fiscal 2026 guidance, keeping all in sales growth for the year in a range of 1% to 5% versus the prior year, while lowering the diluted EPS growth outlook to 1% to 6% from the previous 3% to 9% range, citing higher non core restructuring charges versus fiscal 2025 diluted EPS of US$6.51 (Corporate guidance).Uppdatering av berättelse • Jan 07
PG: Share Repurchase Will Support Future Upside With Stable Long Term Outlook
Narrative Update on Procter & Gamble The analyst price target for Procter & Gamble has shifted slightly, with updated assumptions around fair value at about $168.13, discount rate at 6.96%, revenue growth at roughly 3.12%, profit margin near 19.58%, and future P/E around 26.08x, as analysts fine tune their models on the company. What's in the News Pantene is partnering again with social media creator Alix Earle to promote the Abundant & Strong 3-Step System, including limited-edition Alix x Pantene Kits that bundle the three products with a free cosmetics bag and hairbrush for a limited time (product-related announcement).Uppdatering av berättelse • Dec 16
PG: Share Repurchase Will Support Future Upside Amid Stable Long Term Outlook
Analysts have nudged their price target for Procter & Gamble slightly lower to approximately $168.50 from about $169.05, reflecting modestly softer long term revenue growth expectations that are only partially offset by a marginally improved profit margin outlook and a slightly lower assumed future valuation multiple. What's in the News Pantene launched the Abundant & Strong Collection, a three step system clinically shown to reduce hair loss by up to 85% by targeting scalp oxidative stress with a Pro Vitamin Complex plus Niacinamide technology.Uppdatering av berättelse • Dec 02
PG: Share Repurchase And New Collections Will Drive Continued Momentum
Procter & Gamble's analyst price target remains unchanged at $169.05 as analysts maintain stable estimates based on consistent fair value metrics and minimal adjustments to key financial assumptions. What's in the News Pantene launches the Abundant & Strong Collection, a new three-step system designed to reduce hair loss by up to 85% and promote stronger, denser hair using antioxidant technology.Uppdatering av berättelse • Nov 18
PG: Share Buybacks And New Guidance Will Support Steady Uptrend
Analysts have maintained Procter & Gamble's price target at $169.05 per share. There have been only minor adjustments to underlying valuation factors, supporting a steady outlook for the company.Uppdatering av berättelse • Nov 03
PG: Share Buyback And Product Rollout Will Drive Long-Term Upside
Analysts have slightly raised their price target for Procter & Gamble to $169.05 from $168.64. They cite incremental improvements in revenue growth forecasts even as profit margin projections moderate.Uppdatering av berättelse • Oct 20
Rising Consumer Confidence And Product Investment Will Expand US Markets
Analysts have slightly lowered their price target for Procter & Gamble from $170.95 to $168.64 per share. They cite modest reductions in projected revenue growth, which are partially offset by improved profit margins and valuation multiples.Aktieägarnas avkastning
| PG | US Household Products | US Marknad | |
|---|---|---|---|
| 7D | -1.8% | -1.5% | 1.7% |
| 1Y | -6.2% | -5.7% | 20.0% |
Avkastning vs industri: PG matchade US Household Products branschen som gav -5.7 % under det senaste året.
Avkastning vs Marknaden: PG presterade sämre än US marknaden som gav 20 % under det senaste året.
Prisvolatilitet
| PG volatility | |
|---|---|
| PG Average Weekly Movement | 3.1% |
| Household Products Industry Average Movement | 4.0% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.1% |
Stabil aktiekurs: PG har inte haft någon betydande prisvolatilitet under de senaste 3 månaderna jämfört med marknaden för US.
Volatilitet över tid: PG s veckovolatilitet ( 3% ) har varit stabil under det senaste året.
Om företaget
| Grundad | Anställda | VD OCH KONCERNCHEF | Webbplats |
|---|---|---|---|
| 1837 | 104,000 | Shailesh Jejurikar | www.pginvestor.com |
Procter & Gamble Company tillhandahåller märkesvaror för konsumenter över hela världen. Företaget bedriver sin verksamhet inom fem segment: Skönhet, Kroppsvård, Hälsovård, Textil- och hemvård samt Barn-, dam- och familjevård. Företaget erbjuder balsam, schampo, stylingprodukter och hårvårdsbehandlingar under varumärkena Head & Shoulders, Herbal Essences, Pantene och Rejoice; svettinhibitorer, deodoranter och produkter för personlig hygien under varumärkena Native, Old Spice, Safeguard och Secret; samt ansiktskrämer, rengöringsmedel och hudvårdsprodukter under varumärkena Olay och SK-II.
The Procter & Gamble Company Sammanfattning av grunderna
| PG grundläggande statistik | |
|---|---|
| Börsvärde | US$334.90b |
| Vinst(TTM) | US$15.75b |
| Intäkter(TTM) | US$87.03b |
21.3x
P/E-förhållande3.9x
P/S-förhållandeÄr PG övervärderat?
Se Verkligt värde och värderingsanalysResultat & intäkter
| PG resultaträkning (TTM) | |
|---|---|
| Intäkter | US$87.03b |
| Kostnad för intäkter | US$42.76b |
| Bruttovinst | US$44.28b |
| Övriga kostnader | US$28.52b |
| Intäkter | US$15.75b |
Senast redovisade vinst
Jun 30, 2026
Nästa vinstdatum
Oct 22, 2026
| Vinst per aktie (EPS) | 6.78 |
| Bruttomarginal | 50.87% |
| Nettovinstmarginal | 18.10% |
| Skuld/egenkapitalförhållande | 62.9% |
Hur har PG utvecklats på lång sikt?
Se historisk utveckling och jämförelseUtdelningar
3.0%
Aktuell utdelningsavkastning63%
UtbetalningskvotGer PG en tillförlitlig utdelning?
Se PG utdelningshistorik och jämförelsetal| Procter & Gamble datum för utdelning | |
|---|---|
| Ex utdelningsdag | Jul 24 2026 |
| Utbetalningsdag för utdelning | Aug 17 2026 |
| Dagar till Ex-utdelning | 22 days |
| Dagar till utdelningsdag | 2 days |
Ger PG en tillförlitlig utdelning?
Se PG utdelningshistorik och jämförelsetalFöretagsanalys och finansiella data Status
| Uppgifter | Senast uppdaterad (UTC-tid) |
|---|---|
| Analys av företag | 2026/08/13 18:57 |
| Aktiekurs vid dagens slut | 2026/08/13 00:00 |
| Intäkter | 2026/06/30 |
| Årlig intjäning | 2026/06/30 |
Datakällor
Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.
| Paket | Uppgifter | Tidsram | Exempel US-källa |
|---|---|---|---|
| Företagets finansiella ställning | 10 år |
| |
| Analytikernas konsensusuppskattningar | +3 år |
|
|
| Marknadspriser | 30 år |
| |
| Ägarskap | 10 år |
| |
| Förvaltning | 10 år |
| |
| Viktiga utvecklingstendenser | 10 år |
|
* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.
Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.
Analysmodell och snöflinga
Detaljer om analysmodellen som används för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och handledningar på Youtube.
Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.
Industri- och sektormått
Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.
Källor för analytiker
The Procter & Gamble Company bevakas av 40 analytiker. 22 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.
| Analytiker | Institution |
|---|---|
| Christopher Graja | Argus Research Company |
| Lauren Lieberman | Barclays |
| Bethan Davies | Berenberg |